Bitget App
Trade smarter
MarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project

BUZZ-Caribou shares plunge as company explores sale and cancels cancer project

路透社路透社2026/10/07 09:39
Show original

October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)

- ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72

** Caribou Biosciences said on Tuesday evening that it is exploring strategic options, including a potential sale, merger, or other transactions to maximize shareholder value

** Caribou said it plans to discontinue development of its allogeneic CAR-T cell therapy programs, including vispa-cel for the treatment of non-Hodgkin lymphoma and CB-011 for the treatment of multiple myeloma

** Caribou said it will conduct layoffs and cut costs, and expects most of the layoffs to be completed by the fourth quarter of 2026

** As of June 30, the company held $113.8 million in cash, cash equivalents, and marketable securities

** As of the close of the previous trading session, the company’s shares had fallen about 28% year-to-date


(To better serve non-English native speakers, Reuters provides automated translations of its reports into several other languages. Because machine translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these automated translations, which are provided for the convenience of readers only. Reuters assumes no responsibility for any damage or loss resulting from the use of automated translation features.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Market Chatter: RWE Says Its Uniper Role Would Be Limited After Joint Bid With KKR

06:41 AM EDT, 10/07/2026 (MT Newswires) -- RWE Chief Executive Markus Krebber said any involvement by the German utility in Uniper would be limited after RWE and KKR (KKR) submitted a joint non-binding bid for the state-owned energy company, Bloomberg reported Wednesday. RWE is not targeting a takeover, given its significant position in Germany's energy market, Krebber said in an interview with Bloomberg. RWE did not immediately respond to MT Newswires' request for comment. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

MT newswire•2026/10/07 10:41

BUZZ-"Broker Opinions" Observation: As growth drivers for artificial intelligence continue to increase, Wall Street’s attitude towards Marvell Electronics is becoming more positive.

October 7 - Marvell Technology (MRVL.O) on Tuesday raised its fiscal 2028 revenue forecast to around $20 billions, beating Wall Street expectations, as surging artificial intelligence spending drives growing demand for the company’s custom data center chips. At least 11 analysts have raised their price targets; the median target price among 45 brokerages covering the stock is $325, according to Reuters data. Full speed ahead: Morgan Stanley (rated “Neutral”, target price $300) said the company's long-term targets are achievable in a potential $3 trillion AI infrastructure spending environment, but cautioned that the projected 55%-70% growth leaves almost no room for execution errors, setting a high bar for quarterly results. JPMorgan (“Overweight”, target price $360) noted: "The company is operating at full speed, and the upgraded outlook is not limited to a single product category or customer, but is supported by multiple growth drivers across the data center full stack.” TD Cowen (“Buy”, target price $350) stated that Marvell’s underlying growth momentum has fully shifted to its robust connectivity business, and the risks associated with its custom XPU projects have substantially eased. Melius Research (“Buy”, target price $445) believes that Marvell's market capitalization could reach $1 trillion if the company executes as planned. (For the convenience of non-English speakers, Reuters has automatically translated its report into several other languages. Due to possible errors in automated translation or the absence of required context, Reuters does not guarantee the accuracy of translated texts, which are provided only for reader convenience. Reuters assumes no liability for any damage or loss caused by use of the automated translation feature.)

路透社•2026/10/07 10:36
BUZZ-"Broker Opinions" Observation: As growth drivers for artificial intelligence continue to increase, Wall Street’s attitude towards Marvell Electronics is becoming more positive.

BUZZ-Penguin Solutions shares soar as it raises full-year revenue guidance and beats expectations for Q4 results.

October 7 - **Shares of AI data center infrastructure provider Penguin Solutions (PENG.O) rose 6.3% in pre-market trading to $68.26.** The company raised its fiscal 2027 net sales forecast to a midpoint of about $2.43 billion, up from the previous midpoint of about $2.17 billion; it expects fiscal 2027 revenues to grow 40% year-over-year, with a margin of error of ±10%. **Fiscal 2027 adjusted earnings per share (EPS) are projected at $4.45 (with a fluctuation of plus or minus $0.70), while consensus analyst expectations, according to LSEG data, were at $3.38.** The report shows Q4 revenue at $566.7 million and adjusted EPS at $1, both beating analyst estimates. **All seven brokerage firms covering the stock have a "buy" or higher rating; the median price target is $82.5.** As of the previous trading day’s close, PENG shares are up more than threefold this year, while the S&P 600 Small Cap Index .SPCY has risen just over 15% during the same period. (For the convenience of non-English speakers, Reuters provides automatic translations of its reports into several other languages. Due to the potential inaccuracy of automatic translations or missing context, Reuters does not guarantee the accuracy of these translated texts and provides them solely for the convenience of readers. Reuters assumes no liability for any damage or loss arising from the use of automatic translation features.)

路透社•2026/10/07 10:31
BUZZ-Penguin Solutions shares soar as it raises full-year revenue guidance and beats expectations for Q4 results.